Organization & Developments: NxStage

Parents

2008: NxStage Named Fastest Growing Company in Massachusetts (2008)
2011: NxStage Medical ends deal with medical device supplier (2011)
2017: FDA clears NxStage Medical's System One, allowing for solo home hemodialysis
2017: U.S. Army_Therapeutic Plasma Exchange (TPE) machines
2017: VA_65--NxStage Dialysis Unit
Despite the evidence of these benefits, less than 1% of ESRD patients receive hemodialysis at home, and even fewer receive home daily therapy.
Hundreds of peer-reviewed articles have reported on the clinical and quality of life benefits experienced by patients on more frequent and/or home dialysis—whether in a short or long daily format.
The majority of studies on which these articles were based were conducted before NxStage's products were available, but the literature strongly supports the meaningful benefits associated with more frequent and home dialysis